Latest news
Wall Street Zen Upgrades Foghorn Therapeutics (NASDAQ:FHTX) to Hold - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:05:04 GMTFoghorn’s closing Fayetteville location near Baum-Walker Stadium - KNWA FOX24KNWA FOX24 · Thu, 06 Aug 2026 17:10:01 GMTFoghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Beats Revenue Estimates - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 13:50:06 GMTFoghorn Therapeutics Inc. 2026: Revenue $16.07M, EPS ($0.1) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:11:00 GMTLilly deal lifts Foghorn Therapeutics (Nasdaq: FHTX) Q2 2026 revenue and cuts loss - Stock TitanStock Titan · Thu, 06 Aug 2026 11:03:33 GMTFoghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:00:00 GMTFoghorn’s lung cancer trial advances; IND targeted for 2027 - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMTFoghorn Therapeutics (FHTX) Expected to Release Earnings on Tuesday - MarketBeatMarketBeat · Tue, 28 Jul 2026 07:00:00 GMT